Steven B Klinsky
CIK 1018327 · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AVTR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1633 BROADWAY, 48TH FLOOR
NEW YORK, NY 10019
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NMFCZ | Director | 127,998 | $25.01 | $3.20M | $27.72M | 19 | 2026-03-12 |
| NMFC | Director | 8,329,773 | $6.98 | $58.14M | $57.69M | 26 | 2023-03-21 |
| Signify Health, Inc. (SGFY) Delisted | Director | 67,764 | $30.49 | $2.07M | $0 | 1 | 2022-05-23 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | 10%+ Owner | 609,231 | $0.01 | $7.3K | -$6.58M | 1 | 2021-03-22 |
| New Mountain Finance Corp (NMFX) Delisted | Director | 7,669,913 | — | — | $13.34M | 6 | 2020-06-01 |
| AVTR | 10%+ Owner | 89,591,565 | $15.97 | $1.43B | -$1.99B | 1 | 2020-05-28 |
| DELTEK, INC (PROJ) Delisted | Director | 36,713,972 | — | — | $476.0K | 2 | 2009-05-29 |
| EROC | 10%+ Owner | 5,572,692 | $8.32 | $46.36M | -$2.81M | 1 | 2009-01-21 |
Recent Filings · Page 2 of 7
69 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-09 | NMFCZ | Buy (P) | +34,018 | $399.4K | EDGAR |
| 2024-12-05 | NMFCZ | Buy (P) | +6,200 | $72.8K | EDGAR |
| 2024-11-29 | NMFCZ | Buy (P) | +2,400 | $28.2K | EDGAR |
| 2024-11-26 | NMFCZ | Buy (P) | +36,721 | $430.0K | EDGAR |
| 2024-11-22 | NMFCZ | Buy (P) | +89,044 | $1.03M | EDGAR |
| 2024-11-20 | NMFCZ | Buy (P) | +100,272 | $1.16M | EDGAR |
| 2024-11-18 | NMFCZ | Buy (P) | +97,008 | $1.12M | EDGAR |
| 2024-11-14 | NMFCZ | Buy (P) | +152,353 | $1.76M | EDGAR |
| 2024-11-12 | NMFCZ | Buy (P) | +191,636 | $2.17M | EDGAR |
| 2024-11-08 | NMFCZ | Buy (P) | +210,469 | $2.30M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.